Linezolid is Associated with Improved Early Outcomes of Childhood Tuberculous Meningitis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Linezolid serves as an important component for the treatment of drug-resistant tuberculosis although there is little published data about linezolid use in children, especially in childhood tuberculous meningitis (TBM).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Pediatr. Infect. Dis. J.

Title: The Pediatric infectious disease journal

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1532-0987

ISSN (Print): 0891-3668

Publication date (Electronic): June 2016

Volume: 35

Issue: 6

Affiliations

[1 ] From the *Beijing Children's Hospital, Capital Medical University, Beijing, China; and †Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing, China.

Article

DOI: 10.1097/INF.0000000000001114

PubMed ID: 26901441

SO-VID: d83da161-00b2-4382-80e1-557d6c3d078c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 13

See all cited by